Hideki Sano
Fukushima Medical University
61 Papers
169 Citations
Hideki Sano is an academic researcher from Fukushima Medical University. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 14, co-authored 55 publications. Previous affiliations of Hideki Sano include University of Southern California & Children's Hospital Los Angeles.
Chat about Author
Papers
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
Hideki Sano,Jeffrey Bonadio,Robert B. Gerbing,Wendy B. London,Katherine K. Matthay,John N. Lukens,Hiroyuki Shimada +6 more
TL;DR: This study showed that age tested by using 3 different cut-offs (12, 18, 24 months) was prognostically significant and incorporated age factor (18, 60 months) in the system served better than age by itself for prognostic distinction of pNT patients.
68
Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1
Tsubasa Okano,Kohsuke Imai,Yuki Tsujita,Noriko Mitsuiki,Kenichi Yoshida,Chikako Kamae,Kenichi Honma,Kanako Mitsui-Sekinaka,Yujin Sekinaka,Tamaki Kato,Katsuyuki Hanabusa,Eri Endo,Takehiro Takashima,Haruka Hiroki,Tzu Wen Yeh,Keisuke Tanaka,Masakazu Nagahori,Ikuya Tsuge,Yuki Bando,Fuminori Iwasaki,Yoshiaki Shikama,Masami Inoue,Tomiko Kimoto,Naohiko Moriguchi,Yuki Yuza,Takashi Kaneko,Kyoko Suzuki,Tomoyo Matsubara,Yoshihiro Maruo,Tomoaki Kunitsu,Tomoko Waragai,Hideki Sano,Yuko Hashimoto,Kazuhiro Tasaki,Osamu Suzuki,Toshihiko Shirakawa,Motohiro Kato,Toru Uchiyama,Masataka Ishimura,Tetsuzo Tauchi,Hiroshi Yagasaki,Shiann Tarng Jou,Hsin-Hui Yu,Hirokazu Kanegane,Sven Kracker,Anne Durandy,Daiei Kojima,Hideki Muramatsu,Taizo Wada,Yuzaburo Inoue,Hidetoshi Takada,Seiji Kojima,Seishi Ogawa,Osamu Ohara,Shigeaki Nonoyama,Tomohiro Morio +55 more
TL;DR: Patients with APDS1 showed variable clinical manifestations, and fludarabine‐based reduced‐intensity conditioning–HSCT ameliorated clinical symptoms, but transplantation‐related complications were frequent, including graft failure.
57
Various checkpoint molecules, and tumor-infiltrating lymphocytes in common pediatric solid tumors: Possibilities for novel immunotherapy
Kazuhiro Mochizuki,Satoshi Kawana,Shoki Yamada,Moe Muramatsu,Hideki Sano,Shogo Kobayashi,Yoshihiro Ohara,Nobuhisa Takahashi,Michiyuki Hakozaki,Hitoshi Yamada,Yuko Hashimoto,Atsushi Kikuta +11 more
TL;DR: Results showed that a subset of pediatric solid tumors expressed tumor-associated checkpoint molecules, and TILs expressed corresponding receptors for these checkpoint molecules that may induce favorable immune responses.
33
Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase inhuman eosinophils
TL;DR: Results indicate that GM-CSF and IL-5 activate MAP kinases through the signaling pathway of Jak 2 kinase–tyrosine phosphorylated β chain–phosphatidylinositol 3-kinase– Ras in eosinophils.
32
Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.
Atsushi Kikuta,Masaki Ito,Kazuhiro Mochizuki,Mitsuko Akaihata,Kenji Nemoto,Hideki Sano,Hitoshi Ohto +6 more
TL;DR: The fludarabine-based nonmyeloablative regimen followed by SCT provides a good approach for children with nonmalignant diseases, and even patients with severe organ dysfunctions had adequate engraftment with acceptable toxicities.
28